High genetic diversity of HIV-1 strains in Chad, West Central Africa

被引:31
作者
Vidal, N
Koyalta, D
Richard, V
Lechiche, C
Ndinaromtan, T
Djimasngar, A
Delaporte, E
Peeters, M
机构
[1] IRD, Retrovirus Lab, UR36, F-34394 Montpellier 1, France
[2] Natl AIDS Control Program, NDjamena, Chad
[3] Cooperat Francaise, NDjamena, Chad
[4] Gen Hosp, Reference Lab, NDjamena, Chad
关键词
D O I
10.1097/00126334-200306010-00020
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
The genetic diversity of HIV-1 strains in Chad was documented with a total of 107 samples from patients attending the general hospital in N'Djamena, the capital city of Chad. The genetic subtypes were identified in the V3-V5 env and p24 gag regions by sequence and phylogenetic tree analyses. Of the 107 strains, 78 had the same subtype/CRF designation between env and gag. Four subtypes and three CRFs were found to cocirculate: subtype A, 20.5 %; subtype D, 18.7 %; CRF02_AG, 13.1 %; CRF11_cpx, 13.1 %; subtype G, 3.7%; CRF01_AE, 2.8%; and subtype F1, 0.9%. The remaining 29 strains (27%) had discordant subtypes or CRF designations between env and gag; in 15 of these 29 strains, a CRF was involved in the recombination event, and 10 were subtype G in gag and subtype A in env, forming a separate subcluster within subtypes G and A. Subtype D strains represent almost 20% of the HIV-1 strains circulating in Chad and form a separate subcluster in gag and env. Nearly full-length genome sequencing for two such strains (99TCD-MNO11 and 99TCD-MN012) revealed that they represent nonrecombinant subtype D variants. Compared with neighboring countries, the genetic subtype distribution of HIV-1 strains in Chad is unique for several reasons: lower prevalence of CRF02, high prevalence of CRF11 and subtype D, and absence of CRF06. These data clearly show that subtype distribution is very heterogeneous in Africa, probably the result of different founder effects.
引用
收藏
页码:239 / 246
页数:8
相关论文
共 38 条
[1]   Human immunodeficiency virus type 1 subtype F reverse transcriptase sequence and drug susceptibility [J].
Apetrei, C ;
Descamps, D ;
Collin, G ;
Loussert-Ajaka, I ;
Damond, F ;
Duca, M ;
Simon, F ;
Brun-Vézinet, F .
JOURNAL OF VIROLOGY, 1998, 72 (05) :3534-3538
[2]   Lack of screening test sensitivity during HIV-1 non-subtype B seroconversions [J].
Apetrei, C ;
LoussertAjaka, I ;
Descamps, D ;
Damond, F ;
Saragosti, S ;
BrunVezinet, F ;
Simon, F .
AIDS, 1996, 10 (14) :F57-F60
[3]   Short communication - Molecular characterization of the envelope transmembrane glycoprotein of 13 new human immunodeficiency virus type 1 group O strains from six different African countries [J].
Bibollet-Ruche, F ;
Peeters, M ;
Mboup, S ;
Ekaza, E ;
Gandji, R ;
Torimiro, J ;
Mpoudi, EN ;
Amblard, J ;
Dibanga, G ;
Saidou, M ;
Esu-Williams, E ;
Haesevelde, MV ;
Saman, E ;
Delaporte, E .
AIDS RESEARCH AND HUMAN RETROVIRUSES, 1998, 14 (14) :1281-1285
[4]   The AG recombinant IbNG and novel strains of group M HIV-1 are common in Cameroon [J].
Carr, JK ;
Torimiro, JN ;
Wolfe, ND ;
Eitel, MN ;
Kim, B ;
Sanders-Buell, E ;
Jagodzinski, LL ;
Gotte, D ;
Burke, DS ;
Birx, DL ;
McCutchan, FE .
VIROLOGY, 2001, 286 (01) :168-181
[5]  
Descamps D, 1998, AIDS, V12, P1109
[6]   Susceptibility of human immunodeficiency virus type 1 group O isolates to antiretroviral agents: In vitro phenotypic and genotypic analyses [J].
Descamps, D ;
Collin, G ;
Letourneur, F ;
Apetrei, C ;
Damond, F ;
LoussertAjaka, I ;
Simon, F ;
Saragosti, S ;
BrunVezinet, F .
JOURNAL OF VIROLOGY, 1997, 71 (11) :8893-8898
[7]   Presence of diverse human immunodeficiency virus type 1 viral variants in Cameroon [J].
Fonjungo, PN ;
Mpoudi, EN ;
Torimiro, JN ;
Alemnji, GA ;
Eno, LT ;
Nkengasong, JN ;
Gao, F ;
Rayfield, M ;
Folks, TM ;
Pieniazek, D ;
Lal, RB .
AIDS RESEARCH AND HUMAN RETROVIRUSES, 2000, 16 (13) :1319-1324
[8]   Human immunodeficiency virus type 1 group M protease in Cameroon: Genetic diversity and protease inhibitor mutational features [J].
Fonjungo, PN ;
Mpoudi, EN ;
Torimiro, JN ;
Alemnji, GA ;
Eno, LT ;
Lyonga, EJ ;
Nkengasong, JN ;
Lal, RB ;
Rayfield, M ;
Kalish, ML ;
Folks, TM ;
Pieniazek, D .
JOURNAL OF CLINICAL MICROBIOLOGY, 2002, 40 (03) :837-845
[9]   Predominance of HIV-1 subtype A and D infections in Uganda [J].
Hu, DJ ;
Baggs, J ;
Downing, RG ;
Pieniazek, D ;
Dorn, J ;
Fridlund, C ;
Biryahwaho, B ;
Sempala, SDK ;
Rayfield, MA ;
Dondero, TJ ;
Lal, R .
EMERGING INFECTIOUS DISEASES, 2000, 6 (06) :609-615
[10]   Near full-length genome analysis of HIV type 1 CRF02.AG subtype C and CRF02.AG subtype G recombinants [J].
Janssens, W ;
Salminen, MO ;
Laukkanen, T ;
Heyndrickx, L ;
Van der Auwera, G ;
Colebunders, R ;
McCutchan, FE ;
Van der Groen, G .
AIDS RESEARCH AND HUMAN RETROVIRUSES, 2000, 16 (12) :1183-1189